Categorization of Breast Cyst Fluid and Breast Cancer Risk

[1]  L. Murray,et al.  The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction. , 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  P. Bruzzi,et al.  Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast , 1997, BMJ.

[3]  T. Lennard,et al.  Relationship between basic fibroblast growth factor and transforming growth factor-beta 2 in breast cyst fluid. , 1995, The Journal of clinical endocrinology and metabolism.

[4]  R. Moe,et al.  Identification of multiple proliferative growth factors in breast cyst fluid. , 1993, American journal of surgery.

[5]  L. Brinton,et al.  Breast cancer risk associated with proliferative breast disease and atypical hyperplasia , 1993, Cancer.

[6]  H. Leis.  Gross breast cysts: significance of apocrine type, identification by cyst fluid analysis, and management , 1993 .

[7]  M. Costantini,et al.  Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. , 1992, Cancer research.

[8]  N. Bundred,et al.  Biochemical analysis of breast cyst fluid predicts the natural history of breast cysts , 1992 .

[9]  W. Miller,et al.  Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified? , 1992, Cancer detection and prevention.

[10]  R. Bellantone,et al.  Cathepsin D and epidermal growth factor in human breast cyst fluid. , 1991, British Journal of Cancer.

[11]  G. Secreto,et al.  Accumulation of active androgens in breast cyst fluids. , 1991, European journal of cancer.

[12]  K. V. Patel,et al.  Mitogenic peptides in breast cyst fluid: Relationship with intracystic electrolyte ratios , 1990, International journal of cancer.

[13]  L. Dogliotti,et al.  Estroe‐3‐Sulfate in Human Breast Cyst Fluid a , 1990 .

[14]  R. Molina,et al.  Biochemistry of Cyst Fluid in Fibrocystic Disease of the Breast , 1990, Annals of the New York Academy of Sciences.

[15]  C. Bodian,et al.  Criteria for Classifying Breast Cyst Fluids , 1990, Annals of the New York Academy of Sciences.

[16]  M. Neville.  The Physiological Basis of Milk Secretion a , 1990, Annals of the New York Academy of Sciences.

[17]  L. Dogliotti,et al.  Biochemistry of Breast Cyst Fluid a , 1990, Annals of the New York Academy of Sciences.

[18]  H. Bradlow,et al.  Digoxinlike Materials in Human Breast Cyst Fluids , 1990, Annals of the New York Academy of Sciences.

[19]  L. Dogliotti,et al.  Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: relationships with cyst type. , 1990, European journal of cancer.

[20]  A. Biggeri,et al.  Risk of breast cancer subsequent to proven gross cystic disease. , 1990, European journal of cancer.

[21]  Miller Wr.  The biochemistry of cyst fluids. , 1989 .

[22]  Dixon Jm.  Pathogenesis of cystic disease of the breast. , 1989 .

[23]  Bundred Nj,et al.  Clinical factors influencing the risk of breast cancer in women with gross cysts. , 1989 .

[24]  M. Ghilchik,et al.  Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. , 1989, British Journal of Cancer.

[25]  P. Bruzzi,et al.  Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. , 1988, Cancer research.

[26]  S. Ebbs,et al.  Breast cyst type does not predict the natural history of cyst disease or breast cancer risk , 1988, The British journal of surgery.

[27]  L. Dogliotti,et al.  Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study. , 1988, European journal of cancer & clinical oncology.

[28]  E. B. Scott.  Fibrocystic breast disease , 2003, American family physician.

[29]  L. Dogliotti,et al.  Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. , 1986, European journal of cancer & clinical oncology.

[30]  W. Dupont,et al.  Are breast cysts a premalignant marker? , 1986, European journal of cancer & clinical oncology.

[31]  W. Miller,et al.  Platelet-associated proteins in human breast cyst fluids. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[32]  A. Lumsden,et al.  The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease. , 1985, European journal of cancer & clinical oncology.

[33]  M. Fleisher,et al.  Plasma steroid-binding proteins in the cysts of gross cystic disease of the breast. , 1985, The Journal of clinical endocrinology and metabolism.

[34]  W. Miller,et al.  Natural history of cystic disease: The importance of cyst type , 1985, The British journal of surgery.

[35]  M. Fleisher,et al.  Correlation of concentrations of estriol-3-sulfate with those of potassium and sodium in human breast cyst fluid , 1985, Steroids.

[36]  W. Miller,et al.  pH of human breast cyst fluids. , 1984, Clinical oncology.

[37]  R. Elton,et al.  Risk of breast cancer in women with history of benign disease of the breast. , 1984, British medical journal.

[38]  W. Miller,et al.  The morphological basis of human breast cyst populations , 1983, The British journal of surgery.

[39]  A. Forrest,et al.  Classification of human breast cysts according to electrolyte and androgen conjugate composition. , 1983, Clinical oncology.

[40]  C. Schuerch,et al.  A pathologic study of benign breast diseases in Tokyo and New York , 1982, Cancer.

[41]  M. Fleisher,et al.  Cation levels in human breast cyst fluid. , 1981, Clinical oncology.

[42]  C. Bodian,et al.  Breast Carcinoma: Risk and Detection , 1981 .

[43]  B. Jones,et al.  The presentation and progress of macroscopic breast cysts , 1980, The British journal of surgery.

[44]  W. H. Kern,et al.  Atypical epithelial hyperplasia associated with breast cancer and fibrocystic disease , 1969, Cancer.